Objectives: To assess the performance of the agar disc diffusion method for the detection of carbapenemaseproducing Enterobacteriaceae (CPE) referred to the national reference laboratories (NRLs) in Belgium and France.
Introduction
Carbapenemase-producing Enterobacteriaceae (CPE) isolates have been increasingly reported worldwide.
1 Klebsiella pneumoniae is by far the most frequently encountered CPE species and OXA-48 the most frequent carbapenemase in Belgium and in France.
2,3 Rapid detection of CPE is essential for the control of their dissemination. Ertapenem non-susceptibility has been proposed as the most sensitive marker for the detection of CPE strains, but has shown poor positive predictive value, particularly in geographic areas with a low-prevalence setting. 4 Furthermore, phenotypic methods for the confirmation of carbapenemase production based on the use of inhibitor-supplemented antimicrobial discs allow differentiation between Ambler class A and B carbapenemase producers, but fail to confirm Ambler class D OXA-48-producing CPE. In this study, we evaluated in two different national reference laboratories (NRLs) the ability to detect CPE in carbapenem-non-susceptible Enterobacteriaceae (CNSE) by using the disc diffusion method, with a particular focus on OXA-48-producing Enterobacteriaceae isolates.
Methods
All Enterobacteriaceae isolates referred by local laboratories to the NRLs for non-susceptibility to at least one carbapenem (ertapenem, imipenem, meropenem) according to local routine practice were included for the period from January to December 2012 in Belgium and from March to September 2012 in France. In France, the majority of the laboratories adhered to the recommendations issued by the Comité de l'Antibiogramme de la Société Française de Microbiologie (CA-SFM), 5 while in Belgium the CLSI 6 and EUCAST 7 guidelines were variably used. All isolates were tested for imipenem hydrolysis by the Carba NP assay as previously reported 8 and those with a positive test result underwent multiplex PCR targeting bla VIM , bla IMP , bla NDM , bla KPC and bla OXA-48 for the detection of carbapenemase-encoding genes. 9 Inhibition zone diameters of meropenem 10 mg, piperacillin/ tazobactam 100/10 mg and temocillin 30 mg paper discs (Bio-Rad) tested according to CLSI disc diffusion methodology 10 were measured for all isolates. The recommended susceptibility zone diameter breakpoints chosen in this study were meropenem ≥23 mm, piperacillin/tazobactam ≥21 mm (according to CLSI guidelines) 10 and temocillin ≥19 mm (based on disc diffusion interpretative criteria proposed by Fuchs et al.
11
). To ensure the relationship between disc diffusion inhibition zone diameters and microdilution MICs, 76 randomly selected isolates underwent in parallel MIC determination for meropenem and piperacillin/tazobactam using broth microdilution panels (Sensititre w , Thermo Fisher Scientific, Cleveland, USA). The MICvalue of temocillin was determined by the Etest method (bioMérieux, Marcy-l'Étoile, France).
Results and discussion
In 2012, 635 Enterobacteriaceae isolates referred to the Belgian NRL and 719 referred to the French NRL were analysed. Species and carbapenemase type distribution of the isolates are detailed for each NRL in Table 1 . Overall, from a total of 1354 Enterobacteriaceae isolates screened, 435 (32.1%) were confirmed as carbapenemase producers [OXA-48 (n¼323), KPC (n¼ 60), VIM (n¼ 32) and NDM (n¼ 20)]. While the proportions of each species referred to the NRLs were slightly different (a higher number of Enterobacter cloacae isolates was analysed in France), the proportions of each carbapenemase type and species among confirmed CPE isolates were similar. In Enterobacter spp. decreased susceptibility to ertapenem is common due to extended-spectrum b-lactamase or cephalosporinase production in conjunction with permeability defects. 12 Therefore, the higher number of E. cloacae isolates referred in France may be attributed to the systematic testing of ertapenem by laboratories and the higher screening breakpoint recommended by the CA-SFM (,28 mm) in comparison with the CLSI and EUCAST guidelines used in Belgium.
The distributions of meropenem, piperacillin/tazobactam and temocillin inhibition zone diameters as well as the carbapenemase-encoding genes are shown in Figures 1-3 , respectively. Scattergrams for meropenem, piperacillin/tazobactam and to the antimicrobial agents tested and zone diameter cut-offs selected are detailed in The specificity of combined cut-offs was calculated for carbapenemase-negative isolates when at least one of the two criteria was not fulfilled.
of 80% for the detection of CPE, mainly missing OXA-48 (80/323) and VIM-positive (6/32) isolates. Day et al. 14 reported excellent sensitivities (99%) of different carbapenem (ertapenem, imipenem, meropenem and faropenem) discs and the superior specificity (94%) of faropenem for the screening of CPE isolates. However, this study was conducted in a setting with a different distribution of carbapenemase types, mostly including a large number of NDM producers and a small number of OXA-48-positive strains.
When modified cut-offs were applied (meropenem ,29 mm, piperacillin/tazobactam ,16 mm or temocillin ,12 mm), sensitivity for meropenem was increased to 99.8% while sensitivity for piperacillin/tazobactam remained high at 98.2%. However, specificities using these cut-offs were low for both meropenem (46.0%) and piperacillin/tazobactam (60.5%). With regard to temocillin, 98.1% (317/323) of the OXA-48-producing Enterobacteriaceae isolates displayed disc inhibition zones of ,12 mm compared with only 10.0% (92/919) of the carbapenemase-negative isolates. A more variable distribution of temocillin inhibition zone diameters was found in KPC-and NDM-producing isolates (range 10 -28 and 6 -24 mm, respectively), although the large majority of KPC-producing isolates (52/60) had inhibition zone diameters of ≥12 mm.
These results support previous data and confirm that high-level resistance to temocillin is a highly sensitive and specific phenotypic surrogate marker of OXA-48 production in strains with decreased susceptibility to a carbapenem, although in itself it could not differentiate OXA-48 from VIM-type carbapenemases. 15 -17 When comparing the results obtained for K. pneumoniae with those for other Enterobacteriaceae species, no significant difference in sensitivity of CPE detection was found for either meropenem or piperacillin/tazobactam discs regardless of whether the recommended or the modified cut-offs were applied. Using the modified cut-off of temocillin ,12 mm, the specificity and the positive predictive value for the detection of carbapenemase production were higher in K. pneumoniae (92.0% and 92.9%, respectively) than in other species (89.3% and 61.8%) in which non-carbapenemase mediated resistance to temocillin is more frequently encountered. When applied in geographical areas where OXA-48 represents the predominant carbapenemase, the combination of a piperacillin/tazobactam inhibition zone ,16 mm with a temocillin zone ,12 mm appeared to be highly predictive of carbapenemase production, especially in K. pneumoniae (positive predictive value of 94.6%), while the association of a piperacillin/tazobactam inhibition zone ≥16 mm with a temocillin zone ≥12 mm ruled out the presence of a carbapenemase in 40% (529/1354) of all isolates tested (negative predictive value of 99.2%). Since according to the design of our protocol only strains with a positive Carba NP test were selected for molecular identification of carbapenemases, we retrospectively analysed a subset of isolates displaying high-level resistance to temocillin and to piperacillin/tazobactam, but with a negative Carba NP test result. Overall, none of the 26 available isolates tested (out of 65 isolates) yielded a positive multiplex PCR result, hence excluding the presence of carbapenemases (most notably OXA-48) that could have been missed by the Carba NP test-based algorithm.
In conclusion, our study showed that meropenem CLSI susceptibility breakpoints by the disc diffusion method or cut-off diameters recently proposed by EUCAST 10, 13, 18 fail to detect a substantial proportion of CPE isolates, predominantly OXA-48-producers. This observation is of concern since a large number of microbiology laboratories (50% -60% in Belgium) still rely on the disc diffusion method as the principal method for routine susceptibility testing. Piperacillin/tazobactam and temocillin resistances are highly sensitive surrogate markers for CPE and our study suggests that concomitant susceptibility of CNSE isolates to these two antimicrobials could reliably rule out the presence of a carbapenemase, thus preventing unnecessary additional testing. Finally, in areas where OXA-48 producers are predominant, temocillin testing using a modified zone diameter cut-off of ,12 mm and/ or an MIC .128 mg/L 16 could be an easy and useful tool for discriminating Ambler class D carbapenemase producers from extended-spectrum b-lactamases and/or AmpC-producing isolates among carbapenem-non-susceptible Enterobacteriaceae isolates that yield a negative result by the inhibitor-based combination disc test. 19 Our findings should, however, be evaluated in areas with different epidemiological backgrounds of carbapenemase enzymes.
